OBGYN & Women’s Health
New Rule Requires Health Plans to Disclose Costs Up Front
THURSDAY, Oct. 29, 2020 (HealthDay News) — To make health care costs more transparent, the Trump administration will now require insurance companies to disclose actual prices for common tests and procedures, the Associated Press reported. The new regulations on insurers are designed to empower patients to become better consumers of health care and to help...
FBI Says U.S. Health Care System Under Ransomware Threat
THURSDAY, Oct. 29, 2020 (HealthDay News) — Government agencies are warning that cyberattacks on the U.S. health care system designed to lock up hospital information systems are occurring, the Associated Press reported Thursday. These attacks come at a time of rising cases of COVID-19 and could hurt patient care. In a warning issued Wednesday, the...
Prepregnancy Diabetes Tied to Congenital Anomalies
THURSDAY, Oct. 29, 2020 (HealthDay News) — Prepregnancy diabetes is associated with several subtypes of congenital anomalies of the newborn, according to a study published online Oct. 21 in Diabetes Care. Yuxiao Wu, from the University of Iowa in Iowa City, and colleagues examined the association between maternal prepregnancy diabetes, gestational diabetes mellitus (GDM), and...
Decrease Seen in Non-COVID-19-Related Hospitalizations at Peak
TUESDAY, Oct. 27, 2020 (HealthDay News) — There was a decrease in the frequency of hospitalizations for non-COVID-19-related conditions during the COVID-19 pandemic and in the caseloads of common medical emergencies, according to two research letters published online Oct. 26 in JAMA Internal Medicine. Saul Blecker, M.D., from the NYU Grossman School of Medicine in...
Incident CVD Up With Sugary, Artificially Sweetened Drinks
TUESDAY, Oct. 27, 2020 (HealthDay News) — Higher intake of sugary beverages and artificially sweetened beverages (ASBs) is associated with an increased risk for cardiovascular disease (CVD), according to a research letter published online Oct. 26 in the Journal of the American College of Cardiology. Eloi Chazelas, from Sorbonne Paris Nord University, and colleagues examined...
Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness
TUESDAY, Oct. 27, 2020 (HealthDay News) — Testing of the Eli Lilly antibody drug for hospitalized COVID-19 patients has been halted because the treatment does not help them recover from their infection. Two weeks ago, enrollment in the study was paused because of a possible safety issue, theAssociated Pressreported. But the U.S. National Institute of...
Decrease Seen in Non-COVID-19-Related Hospitalizations at Peak
TUESDAY, Oct. 27, 2020 (HealthDay News) — There was a decrease in the frequency of hospitalizations for non-COVID-19-related conditions during the COVID-19 pandemic and in the caseloads of common medical emergencies, according to two research letters published online Oct. 26 in JAMA Internal Medicine. Saul Blecker, M.D., from the NYU Grossman School of Medicine in...
Quality of Life Varies With Breast Cancer Surgery Type
TUESDAY, Oct. 27, 2020 (HealthDay News) — Young breast cancer survivors who undergo more extensive surgery have worse body image, sexual health, and anxiety compared with women undergoing less extensive surgery, according to a study recently published in JAMA Surgery. Shoshana M. Rosenberg, Sc.D., from the Dana-Farber Cancer Institute in Boston, and colleagues evaluated the...
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
MONDAY, Oct. 26, 2020 (HealthDay News) — Drugmakers AstraZeneca and Johnson & Johnson are ready to resume paused COVID-19 vaccine trials after health scares, CNN reported. The AstraZeneca trial was stopped in early September, and the Johnson & Johnson trial was paused earlier this month. The U.S. Food and Drug Administration authorized the restart after...
More Medical News
